Rimabotulinumtoxinb Side Effects
Brand Names: Myobloc
Please note - some side effects for Rimabotulinumtoxinb may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.
Side Effects of Rimabotulinumtoxinb - for the Consumer
RimabotulinumtoxinB
Applies to: injection
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome when using RimabotulinumtoxinB:
Seek medical attention right away if any of these SEVERE side effects occur when using RimabotulinumtoxinB:Anxiety; back pain; dizziness; drowsiness; dry eyes; dry mouth; flu-like symptoms; headache; increased cough; indigestion; nausea; neck pain; pain, redness, swelling, or tenderness at the injection site; runny nose; sensitivity to light; sweating; upset stomach; weakness of the muscles at or near the injection site.
Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); bleeding at the injection site; chest pain; difficulty swallowing or breathing; double or blurred vision, or other vision changes; drooping eyelid; fever, chills, or persistent sore throat; irregular heartbeat; loss of bladder control; loss of strength; paralysis; pneumonia; seizures; severe or persistent muscle weakness or dizziness; shortness or breath; speech changes or problems; swelling of the hands or feet; vaginal irritation, odor, or discharge; wheezing.
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.
TopSide Effects by Body System - for Healthcare Professionals
Applies to: injectable solution
Cardiovascular
Cardiovascular side effects have included headache (up to 16%) and chest pain.
Dermatologic
Dermatologic side effects including pruritus have been reported in 2% of patients or less.
Gastrointestinal
Gastrointestinal side effects have included dysphagia (up to 25%), dyspepsia (up to 10%), nausea (up to 10%), and to a lesser extent (2% or less) vomiting, glossitis, stomatitis, and tooth disorder.
General
Dry mouth is the most commonly reported adverse effect (occurring in up to 34% of patients). Other general side effects have included torticollis (up to 8%) and, to a lesser extent (2% or less), fever, chills, hernia, malaise, abscess, cyst, and neoplasm.
Genitourinary
Genitourinary side effects reported in 2% of patients or less have included urinary tract infection, cystitis, and vaginal moniliasis.
Immunologic
Immunologic side effects have included infection (up to 19%) and flu syndrome (up to 9%). Other immunologic side effects reported to a lesser extent (2% or less) have included otitis media and viral infection.
Local
Local side effects including injection site pain have been reported (up to 16%).
Musculoskeletal
Musculoskeletal side effects have included neck pain related to cervical dystonia (up to 17%), torticollis (up to 8%), arthralgia (up to 7%), back pain (up to 7%), myasthenia (up to 6%), and asthenia (up to 6%). Other musculoskeletal side effects reported in 2% of patients or less have included arthritis and joint disorder.
Nervous system
Nervous system side effects reported in 2% of patients or less have included anxiety, tremor, hyperesthesia, somnolence, confusion, pain related to cervical dystonia/torticollis, vertigo, and vasodilation.
Respiratory
Respiratory side effects have included increased cough (up to 7%), rhinitis (up to 6%), and, to a lesser extent (2% or less), dyspnea, lung disorder, and pneumonia.
Ocular
Ocular side effects including a case of bilateral ptosis have been reported.
Top- rimabotulinumtoxinb Intramuscular Advanced Consumer (Micromedex) - Includes Dosage Information
- Myobloc Prescribing Information (FDA)
- Myobloc Monograph (AHFS DI)
- rimabotulinumtoxinB MedFacts Consumer Leaflet (Wolters Kluwer)
- rimabotulinumtoxinB Concise Consumer Information (Cerner Multum)
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.


